ABERG LLC</a>, a clinical-stage, artificial intelligence-powered biotech leveraging its proprietary platform, Interrogative Biology®, to map disease and revolutionize treatments across oncology, neurology and rare diseases." /> Niven R. Narain, Author at MedCity News

Niven R. Narain

Dr. Niven R. Narain is CEO of ABERG LLC, a clinical-stage, artificial intelligence-powered biotech leveraging its proprietary platform, Interrogative Biology®, to map disease and revolutionize treatments across oncology, neurology and rare diseases.

Posts by Niven R. Narain